MedTrace Logo

Validation of the STarT Back Screening Tool in the Military

NCT03127826 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 290

Last updated 2022-06-01

No results posted yet for this study

Summary

This is a trial to validate the use of the STarT Back Screening Tool (SBST) in the Military Health System for patients with low back pain presenting to primary care.

Conditions

  • Low Back Pain
  • Lumbago
  • Radiculopathy
  • Intervertebral Disc Disorder

Interventions

PROCEDURE

Risk Stratified Care

Physical therapists providing care will all have attended live training in PIPT principles and be involved in monthly continuing education on these principles. The use of specific principles is guided by the patient's risk stratification (as determined by the STarT Back Tool). Medium Risk: \- Reassurance will be provided to address specific concerns related to their LBP and implications on work High Risk: \- Physical therapy will be psychologically augmented with the assessment of biopsychosocial risk factors and the adoption of cognitive behavioral principles that explore patient concerns and address unhelpful beliefs and behaviors, including tailored education (e.g., stress management and pain neuroscience), graded exercise, \& graded exposure

PROCEDURE

Usual Care

Usual care at the general practitioner's discretion

Sponsors & Collaborators

  • Brooke Army Medical Center

    lead FED

Principal Investigators

  • Daniel Rhon, DPT, DSc · Director of Clinical Outcomes Research, Center for the Intrepid

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-07
Primary Completion
2021-02-26
Completion
2021-07-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03127826 on ClinicalTrials.gov